Physician profile
David A Olvera
NPI 1750585337
$14,461.15
in general payments reported to CMS, 2019-2025
32 companies · $5,396 in 2025
The $5,396 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $1,056 · 2021: $630 · 2022: $1,014 · 2023: $2,403 · 2024: $2,958 · 2025: $5,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,355 · Travel and Lodging: $2,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,355.35 |
| Travel and Lodging | $2,401.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,867.51 | 2019-2025 | Proclaim, Eterna, Infinity |
| Boston Scientific Corporation | $3,560.17 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Stryker Corporation | $1,827.48 | 2024-2025 | Optablate, Mild Device Kit, Spinejack |
| Nevro Corp. | $1,201.59 | 2019-2024 | Senza |
| Globus Medical, INC. | $999.42 | 2025 | Senza |
| Stratus Medical, LLC | $622.72 | 2023 | Nimbus |
| Abbvie INC. | $269.04 | 2022-2025 | |
| Biotronik Nro, INC. | $255.07 | 2024 | Prospera |
| Collegium Pharmaceutical, INC. | $233.82 | 2023-2025 | Belbuca, Nucynta, Xtampza |
| Curonix LLC | $219.20 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Akorn, INC. | $203.53 | 2020 | |
| Hydrocision, INC. | $192.42 | 2024-2025 | Tenjet |
| Nalu Medical, INC. | $162.98 | 2024-2025 | Nalu Neurostimulation System |
| Siemens Medical Solutions USA, INC. | $118.64 | 2025 | Cios Flow |
| Relievant Medsystems, INC. | $111.47 | 2023 | Intracept |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $92.11 | 2019 | |
| Amgen INC. | $79.37 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $73.03 | 2025 | |
| Spr Therapeutics, INC | $65.00 | 2023 | Sprint Pns System |
| Impel Pharmaceuticals LLC | $46.78 | 2025 | Trudhesa |
| Lundbeck LLC | $43.92 | 2022-2023 | Vyepti |
| Pfizer INC. | $38.91 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $24.49 | 2020 | |
| Bioventus LLC | $22.33 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.36 | 2024 | |
| Painteq LLC | $18.11 | 2022 | |
| Medtronic, INC. | $17.63 | 2025 | Inceptiv |
| Azurity Pharmaceuticals, INC. | $16.18 | 2023 | Horizant |
| Kowa Pharmaceuticals America, INC. | $15.86 | 2023 | Seglentis |
| Amneal Pharmaceuticals LLC | $15.33 | 2023 | Lyvispah |
| Forte Bio-Pharma LLC | $14.74 | 2024 | Prolate, Nalocet |
| Avanos Medical | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Olvera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.